Addleshaw Goddard LLP has advised PE house LDC on the management buyout (MBO) of Fishawack Group, a medical communications agency headquartered in Knutsford.
LDC’s investment will allow Fishawack to develop its buy-and-build strategy in a series of targeted acquisitions.
Founded in 2001 by Oliver Dennis and Dominic Miller, who will both continue to lead the business, Fishawack is a provider of scientific marketing and communications services to global pharmaceutical companies. Contracted with 15 of the world’s top 20 pharmaceutical companies, its services are typically provided from phase II/III clinical trial stage through to post-approval and last for the full lifecycle of the patents on compounds.
Headquartered in Knutsford, Cheshire, Fishawack also has sites in Abingdon and Brighton as well as two bases in the US and one in Switzerland and employs more than 230 staff.
The transaction was led by Simon Braham and Jonathan Bell at LDC in Manchester, and both will join the board as non-executive directors.
Fishawack and GCP were advised by BDO (Ruth Percival), with legal advice from Hill Dickinson (Craig Scott and Michael Murphy).
LDC was advised on its investment by Clearwater International (Carl Houghton, Wesley Fell-Smith, Dan Rossington, Mark Taylor, Tom Barnwell, Kirsten Handley and Emma Rodgers), with legal advice from Addleshaw Goddard (Paul Medlicott (in picture) and George Danczuk) and Tax advice from KPMG (Steven Heath and Chris Wilson).